Bafna Pharmaceuticals Ltd vs Blue Jet Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 08, 2026

Key Highlights

The Latest Trading Price of Bafna Pharmaceuticals Ltd is ₹ 132.05 as of 08 May 15:30 . The P/E Ratio of Bafna Pharmaceuticals Ltd is 0 as of March 2021 .The P/E Ratio of Blue Jet Healthcare Ltd is 0 as of March 2021 . The Market Cap of Bafna Pharmaceuticals Ltd is ₹ 0 crore as of March 2021 .The Market Cap of Blue Jet Healthcare Ltd is ₹ 0 crore as of March 2021 . The revenue of Bafna Pharmaceuticals Ltd for the Dec '25 is ₹ 39.51 crore as compare to the Sep '25 revenue of ₹ 36.65 crore. This represent the growth of 7.8% The revenue of Blue Jet Healthcare Ltd for the Dec '25 is ₹ 205.62 crore as compare to the Sep '25 revenue of ₹ 189.75 crore. This represent the growth of 8.36% The ebitda of Bafna Pharmaceuticals Ltd for the Dec '25 is ₹ 4.27 crore as compare to the Sep '25 ebitda of ₹ 5.46 crore. This represent the decline of -21.79% The ebitda of Blue Jet Healthcare Ltd for the Dec '25 is ₹ 60.1 crore as compare to the Sep '25 ebitda of ₹ 79.22 crore. This represent the decline of -24.14% The net profit of Bafna Pharmaceuticals Ltd changed from ₹ -0.72 crore to ₹ 1.84 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Blue Jet Healthcare Ltd changed from ₹ 37.78 crore to ₹ 40.17 crore over 7 quarters. This represents a CAGR of 3.57% The Dividend Payout of Bafna Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Blue Jet Healthcare Ltd changed from 10.59 % on March 2024 to 6.82 % on March 2025 . This represents a CAGR of -19.75% over 2 years .

About Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and is engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non Betalactum products.
The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a.
Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.

About Blue Jet Healthcare Ltd

Blue Jet Healthcare Limited was originally incorporated as Jet Chemicals Private Limited,' at Mumbai, dated December 7, 1968.
The Company name was changed to Blue Jet Healthcare Private Limited', and a fresh Certificate of Incorporation dated December 30, 2020, was issued by the Registrar of Companies, Mumbai.
Subsequently, the status got converted into a Limited Company and its name was changed to Blue Jet Healthcare Limited' on May 18, 2022. The Company is a global, science-led, pharmaceutical company evolved as strategic partner for Collaboration, Development & Manufacturing of Advance Pharmaceutical Intermediates and API. It operate into 3 product categories, contrast media intermediates, high- intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs).

FAQs for the comparison of Bafna Pharmaceuticals Ltd and Blue Jet Healthcare Ltd

Which company has a larger market capitalization, Bafna Pharmaceuticals Ltd or Blue Jet Healthcare Ltd?

Market cap of Bafna Pharmaceuticals Ltd is 313 Cr while Market cap of Blue Jet Healthcare Ltd is 8,521 Cr

What are the key factors driving the stock performance of Bafna Pharmaceuticals Ltd and Blue Jet Healthcare Ltd?

The stock performance of Bafna Pharmaceuticals Ltd and Blue Jet Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bafna Pharmaceuticals Ltd and Blue Jet Healthcare Ltd?

As of May 8, 2026, the Bafna Pharmaceuticals Ltd stock price is INR ₹132.65. On the other hand, Blue Jet Healthcare Ltd stock price is INR ₹491.25.

How do dividend payouts of Bafna Pharmaceuticals Ltd and Blue Jet Healthcare Ltd compare?

To compare the dividend payouts of Bafna Pharmaceuticals Ltd and Blue Jet Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.